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Abstract Lead exposure is a major health hazard affecting children and their 
growth and is a concern in many urban areas around the world. One such city in 
the United States (US), South Bend Indiana, gained attention for its high levels of 
lead in blood and relatively low testing rates for children. We assessed current lead 
screening practices in South Bend and the surrounding St. Joseph County (SJC). The 
2005–2015 lead screening data included 18,526 unique children. Lead screening 
rates ranged from 4.7 to 16.7%. More than 75% of children had ‘elevated blood lead 
levels’ (EBLL) ≥ 1 micrograms per deciliter (µg/Dl) and 9.7% had an EBLL ≥ 5 μg/
dL. Over 65% of the census tracts in SJC had mean EBLL ≥ 5 μg/dL, suggesting 
widespread risk. Inconsistent lead screening rates, coupled with environmental and 
societal risk factors, put children in SJC at greater risk for harmful lead exposure 
than children living in states with provisions for universal screening. Indiana and 
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other states should adhere to the US Centers for Disease Control’s guideline and use 
universal lead testing to protect vulnerable populations.
Keywords Lead poisoning · Testing rate · Universal lead testing
Introduction
Beginning in the early 1900s, manufacturers incorporated lead into a host of prod-
ucts, mostly lead-based paint and leaded gasoline; global contamination of air, 
water, and soil resulted [1]. Global production of lead, largely for lead-acid batteries, 
has increased substantially since the 1970s, even as lead was largely phased out of 
paint and gasoline [1]. Lead poisoning is estimated to kill on the order of 500,000 
people per year globally, with 82% of deaths due to lead occurring in low and mid-
dle income countries [2].
The primary source of lead exposure in low and middle income countries differs 
from the United States (US), with the former dominated by battery manufacturing 
and recycling and the latter by the legacy impacts of lead-based paint and fuel that 
resulted in concentration of lead in surface soils [3]. Globally, young children living 
in proximity to areas with high environmental lead contamination are at greatest risk 
of lead poisoning that can cause detrimental life-long neurological and physiological 
damage [4, 5]. Lead can permanently decrease IQ, academic achievement, and eco-
nomic achievement [6–9]. Further, studies have shown a strong association between 
childhood lead poisoning and criminal arrests [10, 11], as well as other non-cogni-
tive health issues [12, 13].
After decades of progress decreasing lead hazards, the US continues to battle the 
environmental legacy of leaded paint and gasoline. The US Centers for Disease Con-
trol (CDC) reports there are at least 4 million households in the US with high levels 
of environmental lead in which children reside. They further estimate that 500,000 
children ages 1–5 have elevated blood lead levels (EBLLs) above 5  micrograms 
per deciliter (µg/dL), the threshold set by the CDC to initiate case management [6]. 
US state laws governing lead testing of children vary greatly and are implemented 
inconsistently, resulting in abysmal testing rates. In the US, only 10 states and the 
District of Columbia require universal testing and 8 states require targeted testing 
[14]. Targeted testing refers to the criteria established to identify children who are 
at-risk of lead poisoning. The remaining 32 states only have screening recommenda-
tions and no formal policy [14].
The State of Indiana has no formal policy for blood lead screening levels in chil-
dren and the overall lead screening rate in Indiana for all children 0–6 years was 
only 10% [15]. The US federal government finances a medical services program, 
called Medicaid, for some low income children. As part of its services, Medicaid 
requires children enrolled in the program receive lead testing in accordance with 
CDC guidelines [16]. In 2012, 60% of all children in Indiana between 0 and 6 years 
of age were Medicaid-eligible, of whom only 28.7% were tested [17].
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A national survey of the number of children tested and the rates of EBLLs in chil-
dren at the census tract or county level highlighted the failure of the current strategy 
for identifying and protecting children from the harm of lead exposure [18]. The 
survey report pointed to a short list of nine “troubled communities”—those with 
high percentages of children with elevated lead levels—scattered around the US. 
Although large municipalities appeared on this list, so did several smaller communi-
ties with little support for public health surveillance, such as the small post-indus-
trial/university city of South Bend, Indiana. Up to 31% of children under the age of 
7 tested by public and private health providers in South Bend had unsafe levels, the 
highest in the State of Indiana [18].
We aimed to develop an epidemiologic profile of lead testing. We designed our 
study to describe and analyze the demographics and spatial distribution of children 
under 5 years of age (0–4.99 years of age) with elevated lead levels in St. Joseph 
County (SJC), Indiana. This includes South Bend. We chose under 5 years of age to 
be more consistent with CDC screening guidelines, in contrast to Reuters [19] who 
used the state-reported values from 2005 to 2015 for children under 7 years of age. 
We also examined whether blood lead testing rates and trends adequately captured 
those children at highest risk for EBLLs.
Methods
The SJC Health Department maintains a lead database containing the results of 
every blood lead test conducted, along with associated patient information. The 
information captured includes, but is not limited to: demographics, pregnancy sta-
tus, Medicaid status, blood lead level, reason for testing, and physician and labo-
ratory names. For this cross-sectional study, we extracted data between 2005 and 
2015 and de-identified individuals to ensure confidentiality and compliance with 
HIPAA regulations. HIPAA is the Health Insurance Portability and Accountability 
Act of 1996; US legislation that provides data privacy and security provisions for 
safeguarding medical information. As part of de-identification, we aggregated at the 
census tract level the locations of individual residential addresses. We extracted tract 
boundaries for this, and all other spatial analyses, from US Census Bureau TIGER/
Line dataset [20].
After applying exclusion criteria (explained below), 22,629 lead tests represented 
18,526 unique children under 5. Because the data did not allow for appropriate dif-
ferentiation between confirmatory and routine screening, we included the first lead 
test for each unique child only. We are aware that this is slightly different from the 
conventional method using the highest venous or lowest capillary test. We chose this 
method to draw attention to cases without adequate follow-up. Statistically, the con-
ventional aggregation method changes the mean values slightly, but does not impact 
the patterns discussed below.
The exclusion criteria included:
(1) duplicate records,
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(2) records noting the same unique identifier, date of birth, and specimen date report-
ing different blood lead levels,
(3) records with the same unique identifier, but different date of birth,
(4) individuals ≥5 years of age on the date of initial lead test, and
(5) records where the residential address could not be allocated to a specific census 
tract.
We extracted additional data pertaining to population size, poverty level, and 
housing age from the American Community Survey (ACS) 5-year estimates at the 
census tract level in SJC, Indiana.
We performed descriptive analyses for patient demographics and Medicaid status, 
stratified by blood lead level outcomes. We calculated the annual lead testing rate 
of children under 5 at between 2009 and 2015 for several census tracts (ACS yearly 
estimates began in 2009). We generated maps to determine the spatial distribution 
of EBLLs, in addition to indicators such as median housing age and poverty rates. 
We evaluated the correlation between socioeconomic risk factors and EBLLs with 
Spearman’s rank correlation coefficient. We conducted all analyses in R version 
3.4.1 and ESRI ArcGIS 10.5.
Results
Over the 10-year period (2005–2015), health providers performed 22,629 blood lead 
tests for children under 5 years of age. This led to identification of 18,526 unique 
individuals (Table  1). Of the 18,526 unique individuals, 75.5% (14,000) had an 
EBLL ≥ 1 µg/dL.
Both sexes are roughly equally represented in the testing with 49.2 and 50.1% 
females and males, respectively (Table 1). The distribution of EBLL among sexes 
was similar, with a slight increase among males for EBLL 5–9 and ≥ 10 µg/dL. The 
racial composition of the tested individuals consists of 43.3% white, 19.4% black, 
and fewer than 1% for other subgroups, including Asian/Pacific, American Indian, 
and multiracial. With respect to ethnicity, a greater proportion of non-Hispanic indi-
viduals had been tested, compared to Hispanics. The racial and ethnic composition 
is based on a person’s self-identification with a racial/social group as defined by the 
US Census Bureau.
EBLLs are linked to Medicaid status (Table  1). Medicaid status is a proxy for 
low socio-economic status because Medicaid serves children who are from families 
with low income and fewer assets. For children who receive Medicaid, 93.7% had 
an EBLL 1 μg/dL or higher, and for those who were non-Medicaid recipients (usu-
ally higher income), 73.9% had an EBLL ≥ 1 µg/dL (p < 0.0001). Additionally, the 
proportion of Medicaid recipients increases with each incremental rise in blood lead 
level. For example, while 5.8% of Medicaid recipients had a BLL of 0 μg/dl, 26.3% 
were between 1 and 4 μg/dL, 35.2% were between 5 and 9 μg/dL, and 53.7% were 
10 μg/dL or higher.
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Due to poor data collection and/or reporting, a significant proportion of the data 
contained an empty field or was documented as “unknown”. For race and ethnicity 
data, 30.3 and 53.2% of the children, respectively, were recorded as unknown. Simi-
larly, 39.4% of the Medicaid status data of the children was recorded as “unknown”.
Over the 10-year period, lead testing of children was inconsistent (Fig.  1). In 
2011, the number peaked at 2995 children were tested, representing a testing rate of 
16.4%. This peak in testing coincided with a US Housing and Urban Development 
Grant awarded to the South Bend Housing Authority for lead screening. The trend, 
however, steadily declined and in 2015, health care providers tested only 828 chil-
dren, representing a testing rate of 4.7%.
The rate of children identified with EBLL greater than or equal to 5 μg/dL has 
significantly decreased from 178.23 per 1000 in 2007 to approximately 60.0 per 
1000 during 2010–2015 (Fig.  1). When disaggregated by EBLL, the rate of chil-
dren with EBLL 5–9 μg/dL has declined substantially, plateauing from 2010–2015 
at approximately 50 per 1000, while the rate of EBLL  ≥  10  μg/dL has remained 
relatively constant, averaging 18 per 1000.
Table 1  Demographics of children under 5 years of age stratified by elevated blood lead level (EBLL) in 
St. Joseph County, IN; analysis conducted 2017–2018








100% (18,526) 24.4% (4526) 65.9% (12,201) 8.0% (1484) 1.7% (315)
Sex
 Female 49.2% (9122) 50.2% (2271) 49.3% (6014) 47.0% (697) 44.4% (140)
 Male 50.1% (9272) 49.3% (2233) 50.1% (6114) 51.0% (757) 53.3% (168)




0.1% (19) 0.1% (4) 0.1% (10) 0.3% (4) 0.3% (1)
 Asian/Pacific 0.6% (120) 1.0% (45) 0.6% (71) 0.1% (2) 0.6% (2)
 Black 19.4% (3590) 14.1% (640) 20.3% (2480) 25.7% (382) 27.9% (88)
 White 43.3% (8013) 45.4% (2053) 43.3% (5279) 38.7% (574) 34.0% (107)
 Multiracial 0.5% (89) 0.4% (16) 0.5% (65) 0.5% (8) 0.0% (0)
 Other 5.9% (1088) 10.3% (468) 4.7% (575) 2.8% (42) 1.0% (3)
 Unknown 30.3% (5607) 28.7% (1300) 30.5% (3721) 31.8% (472) 36.2% (114)
Ethnicity
 Hispanic 15.9% (2945) 11.8% (534) 16.2% (1981) 23.8% (353) 24.4% (77)
 Non-Hispanic 30.9% (5728) 25.4% (1150) 32.6% (3981) 30.1% (447) 47.6% (150)
 Unknown 53.2% (9853) 62.8% (2842) 51.1% (6239) 46.1% (684) 27.9% (88)
Medicaid status
 Yes 22.5% (4165) 5.8% (265) 26.3% (3209) 35.2% (523) 53.7% (169)
 No 38.1% (7054) 38.4% (1737) 38.0% (4642) 39.7% (489) 27.3% (86)
 Unknown 39.4% (7307) 55.8% (2525) 35.7% (4350) 25.1% (372) 19.0% (60)
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In general, during the period 2005–2015, 9.7% of children tested had a reported 
EBLL of 5 μg/dL or greater. Individuals with an EBLL ≥ 5 μg/dL appear to be 
more centrally located in South Bend within SJC and more densely concentrated 
within nine census tracts, specifically 4, 5, 6, 7, 19, 21, 22, 27, and 30 (Fig. 2a). 
Census tracts 6 and 19 had the highest rates of EBLL  ≥  5  μg/dL at 36.4 and 
30.0%, respectively. Both tend to contain (1) a higher proportion of households 
living in poverty and (2) homes constructed before 1940. Both housing age and 
poverty were associated with an EBLL with a Spearman’s correlation of 0.57 and 
0.58 (p < 0.0001), respectively. The strength of these relationships is indicative 
of multiple factors affecting EBLLs rather than attributing the results to a single 
variable. Disconcertingly, there appear to be low testing rates in these high-risk 
areas, and more specifically, in census tracts with a higher percentage of impover-
ished households. In 2015, between 45 and 60% of individuals in census tract 19 
resided in poverty, but only 5.9% of children under 5 were reported to have been 
tested for lead levels (Fig. 2b).
We examined this lack of testing further using a 7-year time-series analysis. 
We observed low and inconsistent testing rates in several census tracts (Table 2). 
Census tract 19 appears to have the lowest testing rate, with an average of 5.5% 
over the 7-year period. Testing in census tract 27 has been inconsistent, with rates 
ranging between 9.9 and 67.2%. Census tract 6 requires special attention; this 
area has one of the lowest lead testing rates (7.3%) yet contains the highest pro-
portion of children with EBLLs (36.4%).
Fig. 1  Lead testing for children under the age of 5 in St. Joseph County, IN. The number of children 
tested has been inconsistent over the 10-year span, potentially due to gain and loss of monetary incen-
tives to the county health department. The rate of elevated blood level (EBLL) 5–9  μg/dL steadily 
declined while rate of EBLL ≥ 10 μg/dL has remained relatively constant. Analysis conducted 2017–
2018
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Discussion
Blood lead testing rates varied substantially among census tracts and over time 
in SJC, and without any evident strategy to protect children at greatest risk of 
EBLL. On average, only 10% of children under 5 had been tested for lead during 
Fig. 2  Spatial map of a central location in St. Joseph County. a Depicts a cluster of census tracts 
that have a relatively high percentage of children with an EBLL  ≥  5  μg/dL for 2005–2015. Census 
tracts 6 and 19 (shown in red) are considered “hot spots”, with over 30% of tested children having an 
EBLL ≥ 5 μg/dL. b The color represents percentage of individuals living in poverty within that census 
tract; the color deepens with increasing percentage. The superimposed numbers dictate the correspond-
ing lead testing rate within that census tract for 2015. Analysis conducted 2017–2018
Table 2  Lead testing rates 
between 2009 and 2015 in 
children under 5 years of age in 
St. Joseph County, IN
Analysis conducted 2017–2018
Census tracts Years
2009 2010 2011 2012 2013 2014 2015
4 6.9 8.0 22.1 15.8 16.3 7.6 4.9
5 11.9 21.1 35.4 27.3 24.5 17.2 20.8
6 5.6 13.9 43.2 44.1 18.5 16.4 7.3
7 2.2 8.1 22.9 24.4 21.0 13.0 6.1
19 3.2 4.0 4.3 5.2 7.7 8.5 5.9
21 16.4 23.6 29.7 37.3 38.0 20.0 48.7
22 16.3 21.9 38.2 27.6 33.5 17.1 13.3
27 9.9 18.0 67.2 42.5 39.1 11.8 13.3
30 7.2 9.3 16.4 16.8 11.8 21.9 3.6
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2005–2015 and no census tract reached close to the 100% recommended by the US 
CDC. Of the 75 census tracts in SJC, 49 (65%) had an EBLL greater than or equal 
to 5 μg/dL, suggesting that risk exists beyond the center city of South Bend. Such 
low and inconsistent testing make it difficult to draw any conclusion about the scope 
of the EBLL problem among children in SJC. This, in turn, makes it difficult for 
public health officials to allocate resources properly and protect children from lead 
poisoning.
This study shows the importance of describing the environmental and societal 
risk factors associated with EBLL. Housing age and poverty are correlated with an 
EBLL, placing children at greater risk of lead poisoning. Homes constructed prior 
to 1950 were painted with lead-based paint, exposing children to chips of paint and 
leaded dust. Poverty is likely correlated with the state of disrepair of older homes 
and the inability to remediate lead hazards. The spatial analysis shows that older 
homes and poverty are concentrated in the inner city of South Bend, exemplifying 
the negative impact a child’s address can have on his or her health. Spatial analysis 
can aid in the identification of high-risk populations, promoting a more cost-effec-
tive method for resource allocation and targeted testing.
Public health implications
Even after decades of research and legislation to remove lead from paint and gas, 
globally the incidence of lead poisoning remains high in urban areas. Children of 
color in low income households who inhabit the polluted centers of our older cit-
ies without the benefits of adequate nutrition, education, and health care remain at 
particular risk [21]. To create lead-safe environments and to provide environmen-
tal justice for urban dwellers, newer approaches are needed to assess current lead 
exposure mechanisms and to understand fully the health implications of chronic lead 
exposure.
There are significant economic and societal costs associated with lead poison-
ing—and with lack of action to test children, remediate housing, and treat those poi-
soned. At the time the poisoned child enters school, he or she may not be capable 
of performing well without extra educational support (‘special education services’ 
required by law in the US), resulting in increased costs and resources. A child who 
drops out of secondary school is likely to see a significant decrease in lifetime earn-
ings, and that decreases tax revenues and increases social service costs.
Prevention of lead poisoning is cost-effective and necessary to avoid the life-long 
effects and costs. Based upon 2015 data, there were 17,617 children under 5 living 
in SJC. A cost–benefit analysis was conducted to quantify the economic benefit of 
lead exposure prevention and the investment needed to conduct lead screening [22]. 
Given that the cost of a blood lead test ranges from $10 to $75, the cost of screen-
ing 17,617 children in SJC would cost between $176,170 and $1,321,275 [22]. This 
initial investment of $10–$75 would be paid for by public (Medicaid) and private 
health insurance. Our cost–benefit analysis estimates that an investment of $10–$75 
in lead screening would yield a return of $17–$221 in decreased health care costs, 
lifetime earnings, and direct costs of criminal activity [22, 23]. Thus, SJC could 
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expect a return of $2,900,489–$99,399,375. Those returns would be distributed 
across various entities. The health care system (public and private) would achieve 
cost savings because early detection of a lead poisoned child would lower life-time 
health care costs. Schools would serve fewer children with developmental disabili-
ties resulting in a cost savings. Ultimately, children would experience the greatest 
benefit, resulting in greater student achievement and increased lifetime earnings.
This study has demonstrated a lack of coherent laws governing lead testing and 
case management that has led to haphazard and inequitable strategies in Indiana. 
The result is that children are at undue risk for developing long-term problems. 
While Indiana does not have formal policy governing lead testing, states such as 
Maryland, Iowa, and Vermont benefit from laws on universal lead testing for chil-
dren and have achieved significant decreases in lead poisoning rates [14]. Since 
1994, Maryland has accomplished a 98% decrease in childhood lead poisoning, as 
a result of the implementation and enforcement of Maryland’s 1994 Reduction of 
Lead Risk in Housing Act [24]. In Indiana, ‘case management’ remains inconsistent, 
with state law requiring case management for EBLLs ≥ 10 μg/dL and the Indiana 
State Department of Health recommending the initiation of case management for 
EBLLs ≥ 5 µg/dL [15]. Case management includes a nutritional and developmental 
milestones assessment, an environmental assessment to identify the sources of lead 
exposure, and follow-up testing to monitor lead levels [25]. We recommend a state-
wide policy in Indiana that adopts the US CDC’s guideline to require universal lead 
testing and implement case management at 5 µg/dL or higher.
The World Health Organization (WHO) also recognizes that there is a lack of 
guidelines and regulations for lead prevention and management globally. Currently, 
the WHO is developing a set of guidelines to provide evidence-based strategies for 
policy makers and health providers [26].
Recognition of the adverse effects from lead exposure has received international 
attention and, as early as 1989, prompted its inclusion in conventions, such as the 
Convention on the Rights of the Child. While many countries have actively engaged 
in efforts against lead poisoning, especially through the enforcement of bans on 
leaded gasoline and paint, other countries have yet to adopt these measures. A sig-
nificant reduction in blood lead levels in children is a direct result of these restric-
tions. Vigilance in recognizing, reducing, and possibly eliminating other key sources 
of lead, such as lead-acid batteries, is essential in the continued efforts moving for-
ward. To address lead as a global health issue, concurrent action will be needed: sur-
veillance and testing, enacting policy to reduce lead poisoning, coupled with strong 
and consistent implementation.
Mindful of WHO’s objectives and with success seen in other US states, there is 
no safe level of lead; policy makers must act to protect our children and prevent lead 
poisoning.
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